Verily Health receives undisclosed investment from NVIDIA
NVIDIA and existing investor CU Healthcare Innovation Fund II participated in the investment as Verily expands its precision-health platform and patient offering.
Preparing health data for research and care
Verily’s Pre platform harmonizes multimodal health data for analytics, research and AI deployment, while Verily Me brings together patient records to support clinician-reviewed recommendations. The company also develops foundation models such as Forecast 1.0 for long-term health-risk prediction.
Verily said the new investment will support growth of Verily Me and disclosed collaboration with NVIDIA to integrate its AI libraries, frameworks and B200 GPUs into research workflows. The investment amount was not disclosed.
Use of funds
Continue expanding Verily Pre data and AI platform
Grow Verily Me patient engagement offering